Psilocybin mushrooms, functioning in a way similar to LSD as a serotonin 5-HT2A receptor agonist, are a classic form of psychedelic. Currently, these mushrooms are under research for their potential use in psilocybin-assisted therapy for mental health conditions such as severe depression, anxiety, emotional distress, cluster headaches, and migraines.
In order to understand how shrooms can help alleviate these conditions, it’s essential to explore how they metabolize within the body. This knowledge allows researchers and users to understand how the active compound triggers psychological and therapeutic effects. This article aims to offer a basic overview of psilocybin’s pharmacology and pharmacokinetics.
[toc]
Key Takeaways:
- Half of the psychedelic fungi ingested orally gets absorbed and distributed throughout the body.
- Dephosphorylation of the fungi compound occurs via the enzyme alkaline phosphatase, primarily in the liver.
- About 3.4% of the compound gets expelled in its original form within 24 hours, with the majority being excreted as a stable metabolite.
What Does Pharmacokinetics Mean?
Pharmacokinetics (PK) is the science of understanding how the body processes substances, including drugs, once they enter the system. It’s related, but distinct from pharmacodynamics, which studies how a compound interacts with the body. PK primarily focuses on four areas: absorption, distribution, metabolism, and excretion (ADME).
Understanding these processes allows medical professionals to prescribe the most effective medications with the least possible risk. It also enables them to customize treatments based on each patient’s unique physiology and lifestyle.
How Does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the primary active compounds in certain magic mushroom species, have piqued significant interest among researchers and users. Pharmacokinetics investigates how the body processes mushrooms containing psilocybin and helps in understanding their potential effects, whether medicinal or recreational.
These compounds are known by several names, including “magic,” “psychedelic,” “medicinal,” or “sacred.” The fungi containing these compounds are consumed, with The varieties of mushrooms, their origins, sizes, the conditions in which they grow and are dried, along with their age, can result in significant variations in their potency levels.
Even though these mushrooms are naturally found in the wild, scientists have devised ways to create them synthetically in a laboratory. Both naturally occurring and lab-made versions possess low toxicity levels, though they may cause minor side effects such as nausea or vomiting.
Despite these physical side effects, the compounds in mushrooms have demonstrated potential therapeutic benefits because of their safe profile and non-addictive properties. These advantages have encouraged researchers to explore their application in psychotherapy, particularly for the treatment of anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the compound found in these mushrooms, is inactive in its initial form and acts as a prodrug, converting into its active form, psilocin. Enzymes like alkaline phosphatase facilitate this transition, enabling psilocin to be absorbed and distributed in the body, reaching various tissues. However, after being taken orally, psilocybin cannot be detected in the circulatory system, feces, or urine.
Absorption
Absorption is the process by which the compound enters the bloodstream from the site of administration. It determines the speed and effectiveness of the compound reaching its target, such as the plasma. Oral administration is the most common method used. Inhalation has been tried but is not as successful as oral consumption.
The absorption process also encompasses the release of the compound from the dosage form during oral intake. Factors such as delay in the throat or esophagus can affect this, potentially causing a slowdown in the effects or leading to irritation. Once the compound reaches the stomach, the acidic environment may start to decompose it before it enters the bloodstream.
Animal studies suggest that only around 50% of orally ingested psychedelics are absorbed and disseminated throughout the body.
Factors Affecting the Absorption Process
Several factors can influence the absorption process, leading to variations in the onset, intensity, and duration of the effects:
- Stomach Content: A full stomach can slow down the process as it delays the onset of effects. Absorption is faster on an empty stomach. class=”wp-block-heading”>Dispersion
- Body Fat: Substances may accumulate in fat tissues, potentially prolonging their effects.
- Age: Metabolic rates and body composition can vary with age.
- Zero-Order Kinetics: The substance is eliminated at a steady rate, regardless of its concentration.
- First-Order Kinetics: The speed of elimination is dependent on the concentration of the drug.
Dispersion pertains to the process through which psilocin spreads throughout the body once it enters the bloodstream. Psilocin, being lipophilic, can traverse the blood-brain barrier and access the central nervous system.
system.Several factors such as the product’s size, polarity, and protein-binding capability, alongside an individual’s physiological attributes like hydration status and body composition, greatly impact this process.
The aim is to achieve an effective concentration at the targeted site. For effectiveness, the product should reach the intended area, as determined by the volume of distribution, and remain unbound to proteins, thus enabling active interaction with its receptor.
What Factors Affect the Dispersion Process?
Several factors can potentially influence the dispersion process:
Typically, the effects begin to manifest between 20-40 minutes post-consumption, reaching a peak around 80-100 minutes. The effects of magic mushrooms generally last between 4-6 hours.
How Does Dispersion to the Brain Happen?
An initial experimental study conducted on two species demonstrated that its binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also interacts with dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, demonstrating an efficacy of approximately 40%. The psychedelic effects are likely the result of its partial agonist activity at 5HT1A autoreceptors.
The mood-enhancing and psychotomimetic experiences might be the result of the observed correlation between increased dopamine levels and feelings of depersonalization and euphoria. Hallucinogens operate by modifying neurochemistry and receptor activity. They enhance 5HT2A agonist activity by increasing BDNF synthesis in the hippocampus, which subsequently promotes neurogenesis and reduces conditioned fear-related behaviors.
Excretion
Excretion signifies the process by which the
The body expels a substance primarily through the kidneys, but the lungs, skin, and gastrointestinal tract are also involved. In the kidneys, a naturally occurring psychedelic drug is filtered in the glomerulus and secreted in the tubules. The process is further complicated by some reabsorption.
The main compound has a half-life of about 160 minutes, whereas psilocin has a half-life of roughly 50 minutes. Animal studies have demonstrated that the majority of this is excreted in the urine, accounting for approximately 65% within 8 hours. Even after consumption, small traces of the substance can be detected in the bile and feces.
In the human body, around 3.4% of the substance is excreted in its original form within 24 hours. However, most of it is removed as psilocin-O-glucuronide, a more stable metabolite. The stability of this compound allows it to be traced in urine samples over a prolonged period.
There are two main ways that substances are excreted:
Most psychedelic drugs follow the first-order kinetics method, reaching stable concentrations after four to five half-lives. Total removal also occurs after four to five half-lives.
Discover Our Range of Psychedelic Mushrooms
The metabolic process can vary among different types of fungi. When you purchase from trusted online sources like Buy Shrooms Online Canada, you can avoid unintentionally ingesting poisonous mushrooms. Certain types, such as Agaric mushrooms, can induce intense and undesirable effects. Hence, it’s crucial to buy magic mushrooms from reliable suppliers rather than risky street dealers or picking them in the wild.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Extremely high; 3.8% tryptamine content | Moderate to high strength | High strength | |
| Visual Characteristics | Looks like a blob or | Resembles a cauliflower or brain structure | Characterized by typical Cubensis features; of average size | Thick, white stems; caps of golden caramel color; evident blue bruising |
| Effects | Known for its extreme potency; yields intense effects | Powerful cerebral high; delayed onset with significant visuals | Intense visuals and feelings of euphoria |
Online Education on Psilocybin Mushroom Use
Comprehending the pharmacokinetics of shrooms is crucial for medical experts, researchers, and users. Armed with this knowledge, you can make well-informed decisions about dosage and timing, thereby reducing potential risks.
Discover your perfect psychedelic experience at Buy Shrooms Online Canada. Whether you desire a tranquil journey or a deeper exploration, our extensive product selection is crafted to meet your unique needs. Enjoy superior, safe, and rigorously tested shrooms, eliminating worries about ambiguous sources or poisonous mushrooms.
Experience the best magic mushrooms Canada has to offer and take your psychedelic journey to unparalleled heights.
Frequently Asked Questions
Are there any known interactions between shrooms and other medications?
Our products may interact with specific medications, particularly those affecting serotonin levels, like SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) generally lessen the effects, unlike non-serotonergic antidepressants. This reduced effect can continue for up to three months after stopping the antidepressant use.
Do all psychedelics adopt the same pathway as psilocybin?
No, each psychedelic compound has a unique structure that requires different metabolic processes to activate, and they bind to various receptors in the body. The route of administration also affects the absorption of each psychedelic. While the basic principles of absorption, metabolism, and distribution remain the same, the specific pathways and effects diverge for each substance.
Can the mushroom’s form affect the pharmacokinetics?
Yes, the form (be it fresh, powdered, or dried mushrooms) can influence the absorption rate. For example, powdered forms may be absorbed more quickly than whole dried ones due to faster dissolution.
Related Articles:
